Feb 17, 2015 8:00 am EST VolitionRx Limited Announces Exercise of Over-Allotment Option in Previously Announced Public Offering
Jan 7, 2015 8:00 am EST Initial Study Demonstrates that VolitionRx NuQ® Blood Test Has 84% Accuracy in Detecting Early Stage Treatable Pancreatic Cancers
Dec 17, 2014 8:00 am EST VolitionRx to Initiate Study with University Hospital Bonn to Confirm NuQ® Test Accuracy in Lung Cancer
Nov 24, 2014 8:00 am EST VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014
Nov 11, 2014 8:00 am EST VolitionRx Enters Agreement with University of Oxford to Initiate Endometriosis Study
Oct 31, 2014 8:00 am EDT VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection
